Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
AEVIS VICTORIA SA ( (CH:AEVS) ) has issued an update.
AEVIS VICTORIA SA has completed a comprehensive refinancing programme across its group, aimed at optimising its capital and financing structure and improving financial flexibility. At the holding level, the company has secured a new syndicated financing facility, while in the real estate segment it has refinanced a 2020 bridge loan used for hotel acquisitions with long-term mortgage financing and obtained a new facility for London’s Hotel L’Oscar. These measures extend and diversify the maturity profile of AEVIS’s liabilities and, together with a reduction of more than CHF 100 million in consolidated liabilities in the first half of 2025, are expected to significantly lower the group’s cost of debt and financial expenses, delivering annual interest savings in the high single-digit million range.
The most recent analyst rating on (CH:AEVS) stock is a Buy with a CHF17.00 price target. To see the full list of analyst forecasts on AEVIS VICTORIA SA stock, see the CH:AEVS Stock Forecast page.
More about AEVIS VICTORIA SA
AEVIS VICTORIA SA is a Swiss investment company focused on healthcare, lifestyle and infrastructure. Its main holdings include Swiss Medical Network, the only private clinic group with a presence in all three of Switzerland’s language regions; MRH Switzerland AG, a hotel chain with eleven hotels domestically and abroad; Infracore SA and Swiss Hotel Properties AG, both specialising in healthcare and hotel infrastructure; and NESCENS SA, a prevention and better-aging brand. The company is listed on SIX Swiss Exchange under the ticker AEVS.SW.
Average Trading Volume: 16,019
Technical Sentiment Signal: Buy
Current Market Cap: CHF1.15B
See more data about AEVS stock on TipRanks’ Stock Analysis page.